MRFF – EPCDR Initiative– 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity

Overview

The objective of the Medical Research Future Fund (MRFF) – Emerging Priorities and Consumer Driven Research (EPCDR) Initiative - 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity is to support Australian medical research and medical innovation projects in one of the following streams: Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation.  The intended outcome of the research is to improve the health and wellbeing of Australians by supporting research that improves the five-year relative survival rate for ovarian cancer, cancers of the pancreas, liver cancer, lung cancer and cancers with unknown primary site by enabling early diagnosis. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.  Further information on the Medical Research Future Fund is available from the Department of Health website.